HomeComparePFE vs SHW

PFE vs SHW: Dividend Comparison 2026

PFE yields 6.20% · SHW yields 1.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHW wins by $258.2K in total portfolio value
10 years
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →
SHW
SHW
● Live price
1.00%
Share price
$315.90
Annual div
$3.17
5Y div CAGR
76.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$309.3K
Annual income
$185,821.41
Full SHW calculator →

Portfolio growth — PFE vs SHW

📍 SHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFESHW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFE + SHW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PFE pays
SHW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
SHW
Annual income on $10K today (after 15% tax)
$85.30/yr
After 10yr DRIP, annual income (after tax)
$157,948.20/yr
At 15% tax rate, SHW beats the other by $134,819.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFE + SHW for your $10,000?

PFE: 50%SHW: 50%
100% SHW50/50100% PFE
Portfolio after 10yr
$180.2K
Annual income
$106,515.97/yr
Blended yield
59.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SHW right now

PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
SHW
Analyst Ratings
24
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$396.83
+25.6% upside vs current
Range: $371.00 — $420.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFE buys
0
SHW buys
14
PoliticianChamberTickerTypeAmountDate
Jared Moskowitz🏢 House$SHW▼ Sell$15,001 - $50,0002025-10-10
Jared Moskowitz🏢 House$SHW▼ Sell$1,001 - $15,0002025-10-10
Jared Moskowitz🏢 House$SHW▼ Sell$1,001 - $15,0002025-10-10
Ro Khanna🏢 House$SHW▼ Sell$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-08-26
Shelley Moore Capito🏛 Senate$SHW▲ Buy$1,001 - $15,0002025-08-01
Shelley Moore Capito🏛 Senate$SHW▲ Buy$1,001 - $15,0002025-08-01
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-07-25
Valerie Hoyle🏢 House$SHW▼ Sell$1,001 - $15,0002025-07-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFESHW
Forward yield6.20%1.00%
Annual dividend / share$1.72$3.17
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.2%76.6%
Portfolio after 10y$51.1K$309.3K
Annual income after 10y$27,210.54$185,821.41
Total dividends collected$60.1K$277.6K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusHoldBuy
Analyst price target$27.50$396.83

Year-by-year: PFE vs SHW ($10,000, DRIP)

YearPFE PortfolioPFE Income/yrSHW PortfolioSHW Income/yrGap
1← crossover$9,161$701.38$10,877$177.21$1.7KSHW
2$8,610$859.79$11,957$318.14$3.3KSHW
3$8,366$1,081.25$13,371$577.20$5.0KSHW
4$8,483$1,405.66$15,372$1,065.33$6.9KSHW
5$9,084$1,907.24$18,470$2,021.46$9.4KSHW
6$10,418$2,732.78$23,771$4,008.63$13.4KSHW
7$13,007$4,193.56$33,950$8,515.19$20.9KSHW
8$18,010$7,005.87$56,399$20,072.16$38.4KSHW
9$28,216$12,979.89$115,381$55,033.62$87.2KSHW
10$51,081$27,210.54$309,279$185,821.41$258.2KSHW

PFE vs SHW: Complete Analysis 2026

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →

SHWMaterials

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors, and do-it-yourself homeowners. The Consumer Brands Group segment supplies a portfolio of branded and private-label architectural paints, stains, varnishes, industrial products, wood finishes products, wood preservatives, applicators, corrosion inhibitors, aerosols, caulks, and adhesives to retailers and distributors. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications, automotive refinish products, protective and marine coatings, coil coatings, packaging coatings, and performance-based resins and colorants. It serves retailers, dealers, jobbers, licensees, and other third-party distributors through its branches and direct sales staff, as well as through outside sales representatives. The company has operations primarily in the North and South America, the Caribbean, Europe, Asia, and Australia. As of February 17, 2022, it operated approximately 5,000 company-operated stores and facilities. The Sherwin-Williams Company was founded in 1866 and is headquartered in Cleveland, Ohio.

Full SHW Calculator →
📬

Get this PFE vs SHW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFE vs JNJPFE vs MRKPFE vs ABBVPFE vs BMYPFE vs LLYPFE vs SCHDPFE vs JEPIPFE vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.